Evaluation of a Diagnostic Enteric Card for Management of Diarrhea

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

436 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-05-31

Study Completion Date

2009-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

PATH is a member of a consortium that is developing a Diagnostic Enterics Card (DEC) which will allow clinicians to diagnose a group of diarrheagenic pathogens linked to morbidity and mortality. The pathogens detected on DEC include Salmonella, Campylobacter jejuni, Shigella species, and Escherichia coli O157:H7. This study will evaluate the performance of the assays and the platform in clinical conditions with non-expert users. It will provide important data on the performance of DEC for at least one target pathogen, an understanding of the potential impact of different sample types on device performance, and human factors associated with instrument interface in the field.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Point-of-Use Pathogen Identification Tool for Diarrhea

NCT03394040

Diarrhea

TERMINATED

Multidrug Resistant Shigella Infection in Bangladesh

NCT03778125

Diarrhea Shigella

UNKNOWN

Relationship Between C. Difficile Toxins' Serum Level With C. Difficile Infection

NCT03586206

Clostridium Difficile Clostridium Difficile Infection

UNKNOWN

Probiotics Administration Via Colonoscopic Spray and Oral Administration in CDAD Patients

NCT05770726

Diarrhea Infectious

RECRUITING NA

C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.

NCT07250724

Clostridioides Difficile Infection Recurrence

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diarrhea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have 3 or greater liquid stools in the past 24 hours.
* Provide written informed consent from at least one parent in the case of children under 18 years of age.
* Provide written informed consent for those participants above 18 years of age.
* Provide assent in the case of children 10 years of age or greater.

Exclusion Criteria

* Previously enrolled in the study.
* Parents are unwilling or unable to provide written informed consent.
* Report using antibiotics in the last 30 days.
* Adolescent (\<18 years old) parent of a child already enrolled in the study.

Eligible Sex

ALL

Accepts Healthy Volunteers

No